Nasdaq
$3.67▼ 0.68%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.94BShares out 5.300M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
38- 10.15After-hours26.10.16 06:31424B5Offering#●●●#●●●#●●●
RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals (RXRX) is conducting a public offering of 61,540,000 shares of its Class A common stock at a price of $3.25 per share, aiming to raise $200,005,000 in gross proceeds. The company plans to use the net proceeds for general corporate purposes and reported approximately $561 million in cash, cash equivalents, and restricted cash as of September 30, 2026.…more
$3.67-0.68%vs prev closeView filingShare
- 10.15Pre-market26.10.15 21:468-KKey event
RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals has priced an underwritten offering of 61,540,000 shares of its Class A common stock at $3.25 per share, raising approximately $200 million in gross proceeds. Additionally, the company announced a $10 million milestone payment from its partnership with Sanofi and provided positive clinical data updates for its pipeline candidates REC-4881 and REC-1245.…more
$3.67-0.68%vs prev closeView filingShare - 10.15Pre-market26.10.15 21:19424B5Offering
RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals reported approximately $561 million in cash and cash equivalents as of September 30, 2026. The company received a $10 million milestone payment from Sanofi following the option exercise for a development candidate and announced positive Phase 1b/2 data for REC-4881. Additionally, the company is conducting a $200 million offering of its Class A common stock.…more
$3.67-0.68%vs prev closeView filingShare
37 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.16Overnight26.10.16 14:19Bullish#●●●#●●●#●●●
Recursion Pharmaceuticals Announces $200M Stock Offering and Sanofi Milestone…more
Recursion Pharmaceuticals has raised $200 million through a stock offering priced at $3.25 per share. Additionally, the company secured a $10 million milestone payment after Sanofi selected a candidate from their collaborative research program.…more
$3.67-0.68%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.15Pre-market26.10.15 21:42
●●●●●●●● ●●●●● ●●●●●●
Recursion has received a $10 million milestone payment after Sanofi exercised its option on a first-in-class immunology drug candidate. The candidate is expected to enter Phase 1 clinical trials in 2027 under Sanofi's leadership and funding.…more
$3.67-0.68%vs prev closeShareBenzinga - 10.15Pre-market26.10.15 21:28
●●●●●●●● ●●●●● ●●●●●●
Recursion has announced a $200 million underwritten offering of common stock. The issuance of new shares may lead to shareholder dilution, which is typically viewed as a bearish signal for the stock price.…more
$3.67-0.68%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report